Pacira Biosciences
10578 Science Center Drive
Suite 125
San Diego
California
92121
United States
Tel: (858) 625 2424
Website: http://www.pacira.com/
About Pacira Biosciences
At Pacira BioSciences, we have a capable and passionate team of people dedicated to serving our customers in a work environment that encourages collaboration. Our culture inspires and challenges individuals to be effective and efficient in all that they do, and our workforce has a passion for excellence.
OWNERSHIP: Public
Stock Exchange: NASDAQ
STOCK SYMBOL: PCRX
194 articles about Pacira Biosciences
-
Pacira Pharmaceuticals, Inc. Reports First Quarter EXPAREL Revenue Of $34.4 Million And First Quarter 2014 Results
5/1/2014
-
Pacira Pharmaceuticals, Inc. Announces Timing For First Quarter 2014 Financial Results Webcast And Conference Call
4/17/2014
-
Pacira Pharmaceuticals, Inc. Announces Grants Of Inducement Stock Options Under NASDAQ Listing Rule 5635(c)(4)
4/16/2014
-
Pacira Pharmaceuticals, Inc. Announces Proposed Public Offering Of Common Stock
4/8/2014
-
Pacira Pharmaceuticals, Inc. Release: Exparel Use In Femoral Nerve Block For Total Knee Arthroplasty Further Supported By Additional Data From Phase 3 Pivotal Study, SNDA Submission Planned For Second Quarter 2014
4/7/2014
-
Pacira Pharmaceuticals, Inc. Release: Two New Studies Support Use Of EXPAREL For Postsurgical Pain Management Following Total Joint Replacement
3/14/2014
-
Pacira Pharmaceuticals, Inc. Appoints Industry Expert Yvonne Greenstreet To Its Board Of Directors
3/6/2014
-
Pacira Pharmaceuticals, Inc.'s Painkiller, Exparel, Meets Main Goal In Phase 3 Study
2/28/2014
-
Pacira Pharmaceuticals, Inc. Webcast Replay Of 2013 Financial Results Conference Call
2/26/2014
-
Pacira Pharmaceuticals, Inc. Reports 2013 Financial Results: Fourth Quarter EXPAREL Revenues Increase 53 Percent Over Third Quarter
2/25/2014
-
Pacira Pharmaceuticals, Inc. Announces Timing For 2013 Financial Results Webcast And Conference Call
2/11/2014
-
Pacira Pharmaceuticals, Inc. Announces Submission Of Prior Approval Supplement For Additional EXPAREL® Manufacturing Suite
12/6/2013
-
Pacira Pharmaceuticals, Inc. To Present At The 25th Annual Piper Jaffray Healthcare Conference
11/25/2013
-
Pacira Pharmaceuticals, Inc. to Present at November Investor Conferences
11/1/2013
-
Pacira Pharmaceuticals, Inc. Announces Timing for Third Quarter 2013 Financial Results Webcast and Conference Call
10/17/2013
-
Pacira Pharmaceuticals, Inc. Announces Partnership to Support Uptake of EXPAREL® Among the Orthopedic Marketplace
10/2/2013
-
Pacira Pharmaceuticals, Inc. Release: Study Shows EXPAREL® Provided Improved Pain Control, Shorter Length of Hospital Stay and Substantial Cost Savings Following Total Knee Replacement
9/20/2013
-
Pacira Pharmaceuticals, Inc. to Present at the Wedbush 2013 Life Sciences Management Access Conference
8/6/2013
-
Pacira Pharmaceuticals, Inc. Reports Second Quarter EXPAREL® Revenue of $15.2 Million and Full Second Quarter 2013 Financial Results
8/6/2013
-
Pacira Pharmaceuticals, Inc. Pain Drug Fails Late-Stage Trial
8/5/2013